Vodič za dijagnostikovanje i lečenje raka grlića materice - Institut za ...

18. Smernice za celostno obravnavo žensk s predrakavimi spremembami materničnega
vratu / strokovna skupina za pripravo smernic Vršaj-Uršić M. ed Ljubljana : Onkološki
inštitut, 2011
19. Jordan J, Arbyn M, Martin-Hirsch P Schenk U, Baldauf J-J, Da Silva D, Antilla A,
Nieminen P, Prendiville W. European guidelines for quality assurnce in cervical
cancer screening: recommendations for clinical management of abnormal cervical
cytology, part 1. Cytopathology, 2008; 19: 342.354
20. Navratil E, Bajardi F, Nash W. Simultaneous colposcopy and cytology used in
screening for carcinoma of the cervix. Am J Obst Gynecol, 1958; 75: 1292-1297
21. Vergote I, van Der Zee A, Kesic V, Sert B, Robova H, Rob L, Reed N, Luesley D,
Leblanc E, Hagen B, Gitsch G, du Bois A, di Vagno G, Colombo N, Beller U, Ayhan
A, Jacobs I. ESGO statement on cervical cancer vaccination. August 2007. Int J
Gynecol Cancer, (2007), 17: 1-3
22. Arbyn Arbyn M, Rebolj M, de Kok IM, Becker N, O’Reilly M, Andrae B. The
challenges of organising cervical screening programmes in the 15 old member states
of the European Union. Eur J Cancer 2009; 45:2671–8
23. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener A. Herbert A,
L von Karsa. European guidelines for quality assurance in cervical cancer screening
(2 nd ed.). Brussels, Luxembourg: European Community, Office for Official
Publications of the European Communities, 2008.
24. Meijer CJLM, Berkhof J. Cervical cancer—should we abandon cytology for
screening? Nature Reviews Clin Oncol, 2012; 9: 558-559
25. Uredba o nacionalnom programu za prevenciju raka grlića materice. Službeni glasnik
Republike Srbije, broj 54, od 23. maja, 2008, strana 6-11
26. Arbyn M, Ronco G, Anttila A, Meijer JLM C, Poljak M et al, Evidence regarding
human papilomavirus testing in secondary prevention of cervical cancer. Vaccine in
press
27. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the
management of cytology interpretations of atypical squamous cells of undetermined
significance. Am J Obstet Gynecol 2003;188:1383-92.
28. Melnikow J, Nuovo J, Willan AR, Chan BKS, Howell L. Natural history of cervical
squamous intraepithelial lesions: A meta-analysis. Obst Gynecol, 1998;92: 727-735
29. Nygard JF, Skare GB, Thoresen SO. The cervical cancer screening programme in
norwaz, 1992-2000: changes in Pap smear coverage and incidence of cervical
cancer. J Med Screen, 2002; 9:86-91
30. Holowaty P, Miller AB, Riohn T, To T. Natural history of dysplasia of the uterine
cervix. J Natl Cancer Inst, 1999; 91: 252-8
31. Ferris DG, Wright TC Jr, Litaker MS et al. Comparison of two tests for detecting
carcinogenic HPV in women with Papanicolau smear reports of ASCUS and L SIL. J
Fam Pract, 1998; 46:136-41,
32. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-
Luna G Kruger Kjaer S, Muňoz N. Epidemiology and Natural History of Human
Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
Vaccine, 2008; 26S: K1–K16
33. Bornstein J, Bentley J, Bosze P, Girardi F, Haefner H, Menton M, Perrotta M,
Prendiville W, Russell P, Sideri M, Strander B, Torne A, Walker P. 2011 IFCPC
colposcopic nomenclature. In preparation for publication
http://www.ifcpc.org/documents/nomenclature7-11.pdf
34. Colposcopy and Programme Management. Guidelines for the NHS Cervical
Screening Programme. Second edition David Luesley, Simon Leeson eds. ,
NHSCSP Publication No 20 May 2010 BSCCP
35. Ostor AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J
Gynecol Pathol, 1993; 12: 186-192
69